Medivation Announces Third Quarter 2012 Financial Results Teleconference on November 9, 2012
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 11/02/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2012 financial results and provide a general business update on November 9, 2012 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2012 will be released after markets close on November 9, 2012.
Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: . A replay of the webcast will be available on the Company's website for 30 days following the live event.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.11.2012 - 20:15 Uhr
Sprache: Deutsch
News-ID 199151
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 213 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Third Quarter 2012 Financial Results Teleconference on November 9, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
